Back to User profile » Dr Xingmei Duan
Papers published by Dr Xingmei Duan:
Efficient Colon Cancer Immunogene Therapy Through Co-Delivery of IL-22BP mRNA and Tumor Cell Lysate by CLSV Nanoparticles
Huang J, Wang K, Fu X, Zhu M, Chen X, Gao Y, Ma P, Duan X, Men K
International Journal of Nanomedicine 2023, 18:8059-8075
Published Date: 28 December 2023
Targeted siRNA Delivery by Bioinspired Cancer Cell Membrane-Coated Nanoparticles with Enhanced Anti-Cancer Immunity
Li J, Zhang J, Gao Y, Lei S, Wu J, Chen X, Wang K, Duan X, Men K
International Journal of Nanomedicine 2023, 18:5961-5982
Published Date: 24 October 2023
Local and Systemic Delivery of the BimS Gene Nano-Complex for Efficient Oral Squamous Cell Carcinoma Therapy
Ma P, Li J, Gao Y, Wu J, Men K, Li C, Men Y, Duan X
International Journal of Nanomedicine 2022, 17:2925-2941
Published Date: 4 July 2022
Multifunctional Gold Nanoparticles in Cancer Diagnosis and Treatment
Yang Y, Zheng X, Chen L, Gong X, Yang H, Duan X, Zhu Y
International Journal of Nanomedicine 2022, 17:2041-2067
Published Date: 6 May 2022
Functionalized DMP-039 Hybrid Nanoparticle as a Novel mRNA Vector for Efficient Cancer Suicide Gene Therapy
Gao Y, Men K, Pan C, Li J, Wu J, Chen X, Lei S, Gao X, Duan X
International Journal of Nanomedicine 2021, 16:5211-5232
Published Date: 30 July 2021
Treatment of Colon Cancer by Degradable rrPPC Nano-Conjugates Delivered STAT3 siRNA
Zhang H, Men K, Pan C, Gao Y, Li J, Lei S, Zhu G, Li R, Wei Y, Duan X
International Journal of Nanomedicine 2020, 15:9875-9890
Published Date: 7 December 2020
AR-42: A Pan-HDAC Inhibitor with Antitumor and Antiangiogenic Activities in Esophageal Squamous Cell Carcinoma
Zhu Y, Yuan T, Zhang Y, Shi J, Bai L, Duan X, Tong R, Zhong L
Drug Design, Development and Therapy 2019, 13:4321-4330
Published Date: 19 December 2019
Local and systemic delivery of mRNA encoding survivin-T34A by lipoplex for efficient colon cancer gene therapy
Zhang X, Men K, Zhang Y, Zhang R, Yang L, Duan X
International Journal of Nanomedicine 2019, 14:2733-2751
Published Date: 23 April 2019
Co-delivery of Aurora-A inhibitor XY-4 and Bcl-xl siRNA enhances antitumor efficacy for melanoma therapy
Duan X, Mu M, Yan J, Bai L, Zhong L, Zhu Y, Pan H, Zhang M, Shi J
International Journal of Nanomedicine 2018, 13:1443-1456
Published Date: 9 March 2018
Codelivery of SH-aspirin and curcumin by mPEG-PLGA nanoparticles enhanced antitumor activity by inducing mitochondrial apoptosis
Zhou L, Duan X, Zeng S, Men K, Zhang X, Yang L, Li X
International Journal of Nanomedicine 2015, 10:5205-5218
Published Date: 18 August 2015